Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor

  1. Ballester, M.P.
  2. Abril, C.
  3. Merino, V.
  4. Alós, M.
  5. Segarra, G.
  6. Tosca, J.
  7. Montón, C.
  8. Casasus, N.
  9. Lluch, P.
Revista:
Cancer Diagnosis and Prognosis

ISSN: 2732-7787

Ano de publicación: 2024

Volume: 4

Número: 5

Páxinas: 623-630

Tipo: Artigo

DOI: 10.21873/CDP.10373 GOOGLE SCHOLAR